Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study.

In the comparison between AY and CY groups, the proportions of patients with good response were significantly higher in the ABT group than in the csDMARD group at Weeks 52 and 104, but the difference did not reach statistical significance at Week 156 (Fig. 1 a).

also in 111,027 other papers